SAN DIEGO, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento") today announced the completion of the SAD portion of the Phase 1 study of its oral main viral ...
Corbus Pharmaceuticals reports no neuropsychiatric events in CRB-913 trial, advancing to multiple ascending dose phase. Study completion projected for Q3 2025. Corbus Pharmaceuticals Holdings Inc. has ...
No Significant Issues Encountered During the Single Ascending Dose (SAD) Study, Allowing for Previously Reported Accelerated Start to Multiple Ascending Dose (MAD) Part 2 Top Line Data Readout from ...
Fitgurú on MSN
A study reveals that sad music can improve your mental health, this is the playlist that they recommend
In a world where music is a constant companion, a new study has shed light on the positive impact that sad music can have on ...
Jayla Johnson doesn't think so. The 23-year-old who works in brand partnerships in music and entertainment in New York City said those in her generation are simply more brutally honest with their ...
Study demonstrated Ketamir-2 was safe and well tolerated at all dose levels, with a favorable safety and tolerability profile, with no severe or clinically significant adverse effects observed. The ...
The study found that positive tweets were much more contagious than negative ones. So does this actually tell you how Twitter users feel? A major criticism of the Facebook study was that it inferred ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results